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Klebsiella pneumoniae is one of the leading causes of nosocomial infections.
Carbapenem-resistant K. pneumoniae are on the rise globally. The biofilm forming ability
of K. pneumoniae further complicates patient management. There is still a knowledge
gap on the association of biofilm formation with patient outcome and carbapenem
susceptibility, which is investigated in present study. K. pneumoniae isolates from
patients admitted in critical care units with catheters and ventilators were included.
K. pneumoniae (n = 72) were subjected to 96-well plate biofilm formation assay followed
by MBEC assay for subset of strong biofilm formers. Whole genome sequencing and a
core genome phylogenetic analysis in comparison with global isolates were performed.
Phenotypic analyses showed a positive correlation between biofilm formation and
carbapenem resistance. Planktonic cells observed to be susceptible in vitro exhibited
higher MICs in biofilm structure, hence MICs cannot be extrapolated for treatment. The
biofilm forming ability had a significant association with morbidity/mortality. Infections by
stronger biofilm forming pathogens significantly (p < 0.05) resulted in fewer “average
days alive” for the patient (3.33 days) in comparison to those negative for biofilms
(11.33 days). Phylogenetic analysis including global isolates revealed clear association
of sequence types with genes for biofilm formation and carbapenem resistance. Known
hypervirulent clone-ST23 with wcaG, magA, rmpA, rmpA2, and wzc with lack of
mutation for hyper-capsulation might be poor biofilm formers. ST15, ST16, ST307, and
ST258 (reported global high-risk clones) were wcaJ negative indicating the high potential
of biofilm forming capacity. Genes wabG and treC for CPS, bcsA and pgaC for adhesins,
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luxS for quorum sensing were common in all clades in addition to genes for aerobactin
(iutA), allantoin (allS), type I and III fimbriae (fimA, fimH, and mrkD) and pili (pilQ and ecpA).
This study is the first of its kind to compare genetic features of antimicrobial resistance
with a spectrum covering most of the genetic factors for K. pneumoniae biofilm. These
results highlight the importance of biofilm screening to effectively manage nosocomial
infections by K. pneumoniae. Further, data obtained on epidemiology and associations
of biofilm and resistance genetic factors will serve to enhance our understanding on
biofilm mechanisms in K. pneumoniae.
Keywords: K. pneumoniae, biofilm, genome, carbapenem resistance, molecular epidemiology
INTRODUCTION
Klebsiella pneumoniae remains one of the leading causes of
nosocomial infections and declared by WHO as a “priority
pathogen.” In recent times, carbapenem-resistant K. pneumoniae
(CRKP) have been on the rise, leading to multi-drug resistance
(MDR) and limiting treatment options. Emergence of MDR
K. pneumoniae is a cause for current concern in many
countries worldwide with a mortality rate of ∼42% for CRKP
(Xu et al., 2017).
Klebsiella pneumoniae are also known to cause biofilm-
mediated infections in most of the hospitalized patients; this, in
addition to carbapenem resistance, complicates the treatment.
Biofilms are complex mono or polymicrobial structures, result
in persistent prolonged infections, difficult to treat and clear
in vivo. Most of them result from indwelling medical devices
such as catheters and ventilators, expected to be coated with host
cellular factors in situ, leading to nosocomial infections (Murphy
and Clegg, 2012). Biofilm-mediated infections have remained
under-researched for decades and their actual significance in
influencing the outcome of antimicrobial therapy is yet to be
fully understood.
Some of the virulence factors of K. pneumoniae include
capsule polysaccharide, lipopolysaccharide, type 1 and type three
fimbriae, outer membrane proteins and determinants for iron
acquisition and nitrogen source usage (Murphy and Clegg, 2012;
Li et al., 2014). These virulence factors are known to be essential
for the pathogen to evade host immune system and for successful
biofilm formation (Murphy and Clegg, 2012; Li et al., 2014).
The biofilm-forming phenomenon in K. pneumoniae was first
described in 1988 (LeChevallier et al., 1988).
Biofilm formation mechanisms in clinical K. pneumoniae is
reported to be mediated by a series of genes, including allantoin
(allS), aerobactin (iutA), type I (fimA and fimH) and type III
fimbriae (mrkA andmrkD), polysaccharides and adhesins (pgaA,
pgaB, pgaC, and bcsA), capsular polysaccharide (CPS) (wzc, cpsD,
treC, wcaG, wabG, rmpA/A2, magA, k2a, and wzyk2), quorum
sensing (QS) (luxS) and colonic acid (wcaJ) (Wu et al., 2011;
Alcántar-Curiel et al., 2013; Zheng et al., 2018; Pal et al., 2019;
Chen et al., 2020; Hasani et al., 2020). Though these genetic
factors were individually studied, a collective approach on their
analysis in a set of clinical isolates is still lacking.
Antimicrobial resistance (AMR) is a global problem but
very limited data are available on biofilm formation and its
association with AMR among clinical isolates of K. pneumoniae.
This study tries to address the gap in understanding the
effect and association of K. pneumoniae biofilm formation on
AMR in nosocomial infections. In addition, the study provides
information on the epidemiology of K. pneumoniae on their
genetic make-up for biofilm formation and which possibly
enables the success of high-risk clones globally.
MATERIALS AND METHODS
Study Isolates
Isolates with significance from invasive samples in culture were
only considered for inclusion in the study. Accordingly, a total of
72 K. pneumoniae non-duplicate isolates meeting the nosocomial
infections criteria (Garner et al., 1988; Ducel et al., 2002),
previously obtained from clinical samples blood (n = 55) and
endotracheal aspirates (n = 17) from patients in ICU/high-
dependency units at the ChristianMedical College, Vellore, India
between 2018–2019 were selected. These isolates were subjected
to antimicrobial susceptibility and biofilm formation analyses,
and whole-genome sequencing (WGS).
Antimicrobial Susceptibility Testing
Disc Diffusion
Antimicrobial susceptibility testing was performed by the Kirby-
Bauer method with amikacin (30 µg), chloramphenicol (30 µg),
tetracycline (30 µg), gentamycin (10 µg), ciprofloxacin (5 µg),
cefotaxime (30 µg), cefoxitin (30 µg), ceftazidime (30 µg),
cefpodoxime (10 µg), piperacilllin-tazobactam (100/10 µg),
cefoperazone-sulbactam (75/30), netilmicin (30 µg), imipenem
(10 µg), meropenem (10 µg), and tigecycline (15 µg) according
to guidelines suggested by CLSI M100-S29, 2019 (CLSI). Quality
control strains used were Escherichia coli ATCC 25922 for all
antibiotics concurrently in all the batches. Tigecycline results
were interpreted according to FDA criteria.
Minimum Inhibitory Concentration Testing
Minimum Inhibitory Concentration Testing (MIC) tests were
performed for meropenem by the broth microdilution method.
E. coli ATCC 25922 was used as quality control strain
for MIC determination with the expected range of 0.008 –
0.06 µg/ml for meropenem. The interpretive criterion provided
by CLSI Clinical and Laboratory Standards Institute, 2019 for
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susceptible, intermediate and resistant strains were ≤1, 2, and
≥4 µg/ml for meropenem.
Screening for Biofilm Formation
Biofilm Screening Assay
The protocol used was slightly modified from the method
described by Di Domenico et al. (2016). About 5–10 colonies
from fresh culture were inoculated in a 10 ml LB broth and
incubated for 12–18 h at 37◦C. Optical density (OD) was
measured in a spectrophotometer (Shimadzu, Kyoto, Japan) at
625 nm and 0.05 OD cells were prepared by dilution in Mueller-
Hinton broth (MHB) broth (1% glucose). 150µl of prepared cells
were inoculated into each well on a 96 well plate and incubated at
37◦C for 24 h. After incubation, the medium was removed and
the biofilm was washed with 200 µl distilled water. For staining,
200 µl of 0.1% (w/v) crystal violet stain was added and incubated
for 10 min at RT. Wells were washed and destained using 200 µl
of 33% (v/v) glacial acetic acid followed by incubation for 5 min
at RT. OD was read at 570 nm. The assay was performed in
triplicates and a blank well containing only growth medium
without cells were used as negative control for the calculation
of biofilm formation efficiency. Mean and SD was calculated for
statistical significance.
The OD570 values were used to compare and classify
biofilm production semi-quantitatively. Accordingly, the
cut-off OD (ODc) was calculated mean OD of negative
control with three standard deviations. Biofilm production
was classified as: OD < ODc = poor biofilm producer;
ODc < OD ≤ 2 × ODc = weak biofilm producer;
2 × ODc < OD < 4 × ODc = moderate biofilm producer;
and OD ≥ 4 × ODc = strong biofilm producer.
Minimum Biofilm Eradication Concentration
Estimation Assay
An Minimum Biofilm Eradication Concentration (MBEC) assay
was performed for the study isolates using the method previously
described by Chen P. et al. (2014) with slight modifications.
Briefly, all isolates were grown in cation-adjusted MHB with
1% glucose at 37◦C overnight. Cultures were then adjusted for
0.05 OD using MHB and 150 µL of this adjusted inoculum was
added to all the wells (except 1 well – sterility control) in a 96-
well MBEC Assay R© bottom plate (Innovotech, AB, Canada). The
MBEC inoculator plate was then inserted and incubated at 37◦C
for 24 h to allow biofilm formation. After the production of
biofilm in the inoculator plate, four pegs from it were taken using
a sterile tool and tested for the density of biofilm formed.
For this, the removed pegs were put in a fresh 96-well
plate (A1–A4) with 200 µl TSB medium with 1% Tween20
(rich medium) and sonicated in high power for 10 min. After
sonication, 20 µl of inoculum from the suspension (planktonic
cells) in the MBEC bottom plate (any four random wells) were
inoculated in four wells (A5–A8) with 180 µl of rich medium.
The suspensions were then serially diluted up to 10−8 dilutions,
and 10 µl was plated on LB agar followed by incubation at 37◦C
overnight to record the CFU/ml.
The rest of the inoculator plate with biofilm was inoculated
into a 96-well plate containing various concentrations of the
antibiotic in 200 µl MHB in duplicates. The MBEC plate setup
with antibiotics was incubated at 37◦C for 24 h. Following
incubation, the inoculator plate was removed and washed with
sterile distilled water for 1 min and introduced in a 96-well
bottom plate with 200µl of richmedium. The plate was sonicated
for 10 min at high power. Released biofilm cells (sonicated) and
planktonic cells from MBEC bottom plate was serially diluted
up to 10−4 dilutions. 10 µl was plated in LB agar followed by
incubation at 37◦C overnight. The LB plates were recorded for
CFU/ml and the MBEC values were obtained.
Whole Genome Sequencing
Six isolates were sequenced for analysis of carbapenem resistance
and other genetic factors involved. Genomic DNA was extracted
with QIAamp DNA mini kit (Qiagen, Hilden, Germany).
Whole genome sequencing (WGS) was performed using Ion
Torrent (PGM) sequencer with 400-bp read chemistry (Life
Technologies) according to the manufacturer’s instructions. The
data was assembled de novo using AssemblerSPAdes v5.0.0.0
embedded in Torrent suite server version 5.0.3. The sequence
annotation was performed in NCBI Prokaryotic Genomes
Automatic Annotation Pipeline (PGAAP)1. Downstream
analysis was done using the Center for Genomic Epidemiology
(CGE) server2.
Genome-Wide Association and
Phylogenetic Analysis
In addition to the six isolates sequenced in this study, complete
genome sequences of 473 isolates (451 K. pneumoniae
and 22 K. quasipneumoniae) with reported biofilm
genotypes were selected and downloaded from NCBI
for a global comparison of the study isolates. Search
terms used were “K. pneumoniae + biofilm;” “Klebsiella
quasipneumoniae + biofilm.” Accordingly, K. pneumoniae
and K. quasipneumoniae were analyzed separately for their
phylogenetic relations. Fasta sequences were used to call core
SNPs using Snippy v4.4.03 and recombinations were removed
using Gubbins v2.0.0 (Croucher et al., 2014). RAxML program
was used to build the phylogenetic trees using the clean core SNP
alignments generated from Gubbins.
Obtained 473 fasta sequences were annotated using Prokka
v1.14.6 for further analysis (Seemann, 2014). The isolates
were analyzed using Roary v3.11.2 (Page et al., 2015) with
Mafft v7.467 to identify the core genes involved among the
selected population of K. pneumoniae, which was used to
study the genes involved in biofilm production. Sequences
were then analyzed using ABRicate v0.8.7 for their AMR
genes and plasmids; MLST was identified using mlst v 2.18.0
algorithm4. Country-wise distribution of carbapenemases and
mcr genes and their association with sequence types (STs) in
454 K. pneumoniae including study isolates was mapped using
1https://www.ncbi.nlm.nih.gov/genome/annotation_prok/
2http://www.cge.cbs.dtu.dk/services
3https://github.com/tseemann/snippy
4https://github.com/tseemann/mlst
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mapchart.net5. Individual biofilm gene sequences were retrieved
using a blast algorithm, which were further subjected to Snippy
for generating a core alignment and the tree was built using
RaxML. All trees generated in the study were visualized using
iTOL v 5.5.1. Scoary v1.6.16 was used for genotypic association
analysis with parameters “-c I EPW -p 0.1 0.05–collapse” by
providing core genome alignment tree generated by Roary
(Brynildsrud et al., 2016).
This Whole Genome Shotgun project has been deposited
at GenBank under the accession numbers JAAMFF00000000,
JAALJL00000000, JAALJK00000000, JAAMFE00000000,
JAAMFD00000000, and JAALJJ00000000.
Statistical Analysis
Clinical characteristics were recorded in Microsoft Excel 2016
(Roselle, IL, United States) and analyzed for significance in
SPSS 16.0 using t-test. Logarithmic growth values of meropenem
treated biofilms were calculated as mean± SD of triplicate values.
GraphPad Prism v8.2.0 was used to generate the MBEC graph.
Correlation of AMR and biofilm virulence genes were recorded as
significant only if Benjamini-Hochberg’s p-value were p < 0.05.
RESULTS
Antimicrobial Resistance
Among the 72 isolates tested from patients under critical care,
∼20% had carbapenem susceptibility, followed by minocycline
and tigecycline, with 30 and 45% susceptibilities, respectively.
In contrast, most of other tested antimicrobials had <20%
susceptibility (Supplementary Table 1).
Association of Carbapenem Resistance
and Clinical Outcome With Biofilm
Formation Efficiency
The biofilm formation assay revealed that out of 72 isolates
tested, 27.78% (n = 20) were strong biofilm producers with a
positive correlation with carbapenem resistance compared to
moderate (22.22%), weak (19.44%) and negative (30.56%) biofilm
formers (Table 1).
Comparison of mortality and length of hospital stay from
the onset of infection revealed the average “days alive” of a
5https://mapchart.net/
patient for weak biofilm was 4.83, moderate biofilm was 3.875,
strong biofilm forming pathogens was 3.33. This was significantly
low (p < 0.05), when compared to 11.33 days for patients
with isolates negative for biofilm production (Table 1). In
addition, the number of patients expired were significantly higher
(38.2%) in infections with strong biofilm formingK. pneumoniae,
in comparison with biofilm negative K. pneumoniae (17.65%)
(Supplementary Table 1).
Interestingly, around 62% (n = 45) of the patients with
K. pneumoniae were found co-infected with bacterial and
yeast pathogens, with both monomicrobial and polymicrobial
co-infections (Figure 1). Pathogens obtained in addition to
K. pneumoniae from same patient were considered as co-
infection. These included P. aeruginosa (n = 11), Acinetobacter
spp. (n = 11), non-fermenting Gram-negative bacteria (NFGNB)
(n = 4), E. coli (n = 5), Klebsiella spp. (n = 2), Enterococcus spp.
(n = 5), S. aureus (n = 4), CoNS (n = 9), Group B Streptococcus
(GBS) (n = 2), Aeromonas spp. (n = 1), and yeast (n = 12). There
was no significant difference between the numbers in groups of
strong, moderate, weak and negative biofilm producers.
MBEC Analysis
The MBEC of meropenem differed in comparison to MICs for
the eight strong biofilm forming K. pneumoniae isolates tested
(Table 2). The MBEC values for biofilms were higher than
the MIC values estimated for planktonic cells. The quantitative
log growth values (CFU/ml) of K. pneumoniae at various
concentrations of meropenem were depicted in Figure 2. The
values depict the actual representation of microbial population
unaffected by meropenem in the biofilm structure. Isolates
C1, C2, C4, and C6 had exhibited ≥128 µg/ml as MBEC
values, whereas C3, C7, and C8 required ≤4 µg/ml for
clearing the biofilms.
Genome Analysis of K. pneumoniae and
K. quasipneumoniae
A representative sample of six strong biofilm forming
K. pneumoniae were sequenced to ∼60× coverage. WGS
revealed three of these isolates to be K. quasipneumoniae. These
were compared with global isolates obtained from NCBI for
further analysis. Core genome analysis of 454 K. pneumoniae
using Roary revealed 1129 core genes (in 99%), 1511 soft core
(95–99%) and 3439 shell genes (15–95%), 36,072 cloud genes
(<15%), total 42,151, whereas for 25 K. quasipneumoniae, 4,931
TABLE 1 | Distribution of carbapenem resistance, mortality and average days alive among patients with strong, moderate, weak, and negative biofilm forming
K. pneumoniae infections.
(n = 72) % of isolates % Carbapenem
Resistance
% Of patients with
negative outcome
(expired)
Average no. of days
alive between culture
positive and expiry
% Of patients with
positive outcome
(discharged)
Strong biofilm (n = 20) 27.78 90* 38.24* 3.33* 20.59*
Moderate biofilm (n = 16) 22.22 81.25* 26.47* 3.875* 17.65*
Weak biofilm (n = 14) 19.44 85.71* 17.65 4.83* 17.65*
Negative (n = 22) 30.56 68.18 17.65 11.33 44.12
*P < 0.0001 – Significant difference when compared to the negative biofilm formers.
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FIGURE 1 | Pathogens co-infecting patients with K. pneumoniae. (A) Of 45 K. pneumoniae infections, 33 were co-infected with bacteria, five with yeast and seven
were mixed infections. Also depicted is the number of each clinical pathogen among the bacterial co-infected population. (B) Numbers on each category with
classification under strong, moderate, weak, and negative biofilm forming K. pneumoniae.
core genes, 1,394 shell genes, and 6,325 total genes were found.
Total SNPS included for phylogenetic analysis were 1,80,537 for
K. pneumoniae and 1,97,628 in K. quasipneumoniae.
Association of Global Clones With Genes
Responsible for Biofilm Mechanism and
Carbapenem Resistance
Among both K. pneumoniae and K. quasipneumoniae, genes
responsible for biofilm formation, allS (aerobactin), iutA
(allantoin), type 1 fimbriae (fimA, fimH), type III fimbriae
(mrkD), pili (pilQ, ecpA), adhesins/polysaccharides (pgaA, pgaB,
TABLE 2 | MBEC values of meropenem toward biofilm forming clinical
K. pneumoniae.
Isolate ID MIC by broth
microdilution for
planktonic cells
MBEC for
biofilm
MBEC for
planktonic released
from biofilm
C1 32 (R) 512 (R) 1024 (R)
C2 32 (R) 128 (R) 128 (R)
C3* ≤0.03 (S) 2 (I) 2 (I)
C4 16 (R) 128 (R) 128 (R)
C5* ≤0.03 (S) 32 (R) 32 (R)
C6* ≤0.03 (S) 128 (R) 128 (R)
C7 16 (R) 4 (R) 4 (R)
C8* ≤0.03 (S) 4 (R) 4 (R)
*Isolates with susceptible MIC but resistant to meropenem in biofilm structure
(MBEC); R – resistant, I – intermediate, S – susceptible.
pgaC, and bcsA), CPS (wzc, cpsD, treC, wcaG, wabG, rmpA/A2,
magA, k2a, and wzyk2), QS (luxS), colonic acid-mucoid (wcaJ)
were screened and presented in Figures 3, 4, respectively. The
AMR and biofilm gene profile of the six isolates were compared
in Table 3. None of the isolates sequenced in this study harbored
known mutations in the porin genes ompK35, ompK36, and
ompK37.
The genes present among theK. quasipneumoniae isolates (C3,
C5, and C6) justifies their susceptibility to carbapenems by lack
of strong ß-lactamases, which is otherwise present in C1, C2, and
C4 (K. pneumoniae). However, C3 was intermediate resistant; C5
and C6 were resistant tomeropenem byMBEC assay. In addition,
biofilm gene profile of K. quasipneumoniae were significantly
different from K. pneumoniae for cohesion and CPS factors.
In K. pneumoniae, among 454 genomes (451 Genbank + 3
sequenced) the comparison of STs correlated well with the
biofilm forming virulence genes, AMR genes and country of
isolation. Among the sequenced isolates, two K. pneumoniae
belonged to ST395, one K. pneumoniae belonged to ST2096 and
three K. quasipneumoniae isolates belonged to ST1813. ST11
and ST258 (CC11) were the major clades harboring blaKPC
for carbapenem resistance. These clades were predominantly
observed in the Americas, Europe and China. ST11 were
predominantly seen in China, with only small numbers in
United States, Europe and Taiwan. Isolates from Europe and
Taiwan alone harbored blaOXA−48 like carbapenemases instead
of blaKPC. A fraction of isolates from China harbored blaNDM
either alone or in addition to blaKPC. In contrast, ST258 was a
strict blaKPC clone and did not harbor any other carbapenemases.
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FIGURE 2 | MBEC assay comparing the biofilm eradication efficiency of meropenem in vitro on K. pneumoniae with biofilm structure. X-axis indicates concentration
of meropenem used for treatment, Y-axis indicates log10 CFU/ml of cells at respective concentrations. Data was visualized using GraphPad Prism v8.2.0. Biofilm –
K. pneumoniae biofilm structure formed on pegs; Released planktonic – Cells released from the biofilm structure on pegs during meropenem treatment.
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FIGURE 3 | Core genome phylogeny of strong biofilm forming clinical K. pneumoniae in comparison to global genomes for identifying similarities in biofilm virulome
and resistome. The color of branch leaves indicate the bootstrap values, green indicating high; red indicating low. STs were marked in color ranges; innermost circle
represents biofilm virulome (allS, iutA, fimA, fimH, mrkD, pilQ, ecpA, pgaABC, bcsA, wzc, cpsD, treC, wcaG, wabG, rmpA/A2, magA, k2a, wzyk2, luxS, and wcaJ)
followed by resistome (blaIMP, blaVIM, blaNDM, blaKPC, blaOXA−48 like, and mcr) as shape plots. Location of each isolate has been given in the outermost ring as color
strip.
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FIGURE 4 | Comparison of K. quasipneumoniae clinical isolates to the global complete genomes indicating the biofilm virulome and resistome. The color of branch
leaves indicate the bootstrap values, green indicating high; red indicating low. STs were marked in color ranges followed by biofilm virulome (allS, iutA, fimA, fimH,
mrkD, pilQ, ecpA, pgaABC, bcsA, wzc, cpsD, treC, wcaG, wabG, rmpA/A2, magA, k2a, wzyk2, luxS, and wcaJ) and resistome (blaIMP, blaVIM, blaNDM, blaKPC,
blaOXA−48 like, and mcr). Color strips indicate the country of the isolate.
TABLE 3 | Comparison of AMR and biofilm gene profile between K. pneumoniae and K. quasipneumoniae.
Isolate ID STs ß-lactamases Adhesin Cohesion CPS QS Colanic acid Allantoin aerobactin
C1 395 blaCTX−M−15, blaOXA−1, blaSHV−182,
blaNDM−5
fimA, fimH,
mrkD, ecpA
pgaC cpsD, wabG luxS wcaJ allS iutA
C2 395 blaCTX−M−15, blaOXA−1, blaTEM−1B,
blaSHV−11, blaSHV−182, blaNDM−5,
blaOXA−232
fimA, fimH,
mrkD, ecpA
pgaC cpsD, wabG luxS allS iutA
C4 2096 blaCTX−M−15, blaOXA−1, blaDHA−1,
blaTEM−1A, blaSHV−28, blaSHV−106,
blaNDM−5
fimA, fimH,
mrkD, pilQ
pgaB, pgaC wabG,
rmpA2
luxS allS iutA
C3* 1813 blaDHA−1, blaOKP−B−1 fimA, fimH,
mrkD, pilQ,
ecpA
pgaA, pgaB,
pgaC
treC, wabG luxS allS iutA
C5* 1813 blaDHA−1, blaOKP−B−1 fimA, fimH,
mrkD, pilQ,
ecpA
pgaA, pgaB,
pgaC
treC, wabG luxS allS iutA
C6* 1813 blaDHA−1, blaOKP−B−1 fimA, fimH,
mrkD, pilQ,
ecpA
pgaA, pgaB,
pgaC
treC, wabG luxS allS iutA
*K. quasipneumoniae; susceptible to meropenem by MIC; STs – Sequence types.
ST258 was predominantly found in United States followed by
fewer isolates in Europe and Australia.
ST11 harbored most of the genes required for the process
of biofilm formation, allS, iutA, fimA, fimH, mrkD, pilQ, ecpA,
pgaA, pgaB, pgaC, bcsA, cpsD, treC, and wabG. ST258 also carried
the same set of genes for biofilm except pgaB, which was clearly
missing in ST258. Both ST11 and ST258 did not harbor wzc,
wcaG, magA, k2a, and wzyk2 for CPS. rmpA and rmpA2 were
found in few of the ST11 isolates (n = 20) from China. Almost
50% of ST11 from China lacked wcaJ known for colanic acid
production, while none of ST258 isolate carried wcaJ.
ST395 (CC395) was typically missing pgaA and pgaB genes
for polysaccharide production. They were distributed in the
United States (n = 2), India (n = 2), China (n = 1), and Germany
(n = 1). One of the United States isolates carried k2a and
wzyk2 genes for K2 serotype. Two of the study isolates from
India (C1 and C2) lacked bcsA and treC in addition to pgaA
and pgaB. These isolates harbored only one gene for adhesin
(pgaC), while carrying cpsD, treC, and wabG for CPS. Except two
isolates from India (C1) and United States, none of ST395 carried
wcaJ. Four out of six ST395 isolates harbored blaNDM, with one
Indian isolate harboring both blaNDM and blaOXA−232. One of
the two isolates lacking blaNDM was found harboring blaOXA−48
like. Interestingly, one isolate from China that completely lacked
carbapenemases carried anmcr gene.
ST307 (CC307), which is again a blaKPC predominant clone,
was observed in the United States and South Korea. This clone
lacked the pgaB gene for adhesin but carried treC and wabG
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for CPS. ST16 is an another reported MDR clone, observed in
United States and Europe, with one isolate each in Thailand,
Vietnam and South Korea. ST16 had a mixture of blaNDM
and blaOXA−48 like carbapenemases. Interestingly, one isolate
each from Thailand and Vietnam harbored mcr in addition to
blaNDM. ST16 harbored only treC andwabG for CPS but harbored
all other screened genes for type I and III fimbriae, adhesins,
aerobactin and allantoin.
ST147 (CC147) is a reported K. pneumoniae global clone
and was observed across all countries. However, based on
the geographical occurrence, the carbapenemase genes carried
differed. ST147 K. pneumoniae from Germany (n = 8), UAE
(n = 2), Pakistan (n = 1), and Nepal (n = 1) harbored
blaOXA−48 like, while one isolate from Greece harbored blaKPC.
blaNDM was observed in ST147 from Singapore, Switzerland,
United Kingdom and Canada. In addition, a combination of
blaNDM and blaOXA−48 was observed in South Korea (n = 2) and
Czech Republic (n = 1). ST147 from United States harbored both
blaNDM and blaKPC, while two isolates from China harbored each
with blaKPC + blaVIM and blaNDM + blaIMP. One ST147 isolate
from Thailand carried an mcr gene for colistin resistance. ST147
from Sweden (n = 2) did not harbor any carbapenemases in 2009,
later in 2012 an isolate found acquired blaOXA−48 like. ST147
lacked pgaA and pgaB genes for adhesin, instead harbored pgaC,
bcsA. For CPS ST147 carried only treC and wabG, while carrying
wcaJ for colanic acid.
ST23 (CC23) was mostly found in China, with a few isolates
identified in United States, South Korea and India. Few isolates
from China and United States alone carried blaKPC, whereas one
isolate from China and India carried blaVIM and blaOXA−48 like,
respectively. ST23 harbored all screened genes for aerobactin,
allantoin, fimbriae, pili, and adhesins except pgaA. For CPS, they
exclusively carried wzc and magA gene in addition to wabG and
treC, which was not seen in any related/unrelated STs. Also,
wcaG, and rmpA/A2 were seen majorly in ST23 with very few
reports in other STs. Since these were the only ST harboring wzc
genes for CPS, they were further analyzed for their efficiency in
producing hyper-capsulation by carrying a 565 glycine-to-serine
substitution in wzc genes. The analysis revealed that none of the
isolates were mutated at 565 glycine-to-serine position, known
for hyper-capsulation.
ST231 (CC43) and ST101 (CC11) are blaOXA−48 carrying
clones thought to be split from a single parent clade but still
appear to converge in the core gene characteristics that are
evident in their biofilm and AMR gene profiles. In this study
population, ST231 was identified in India and the United States.
Interestingly one isolate from ST101 carried blaKPC from India.
Both ST231 and ST101 lacked pgaA and pgaB genes for adhesins
and carried only treC and wabG for CPS. Most of ST231 and
ST101 lacked wcaJ for colanic acid. Similarly, ST14 (CC14) and
ST15 (CC15) were diverged from a single parent clade found
across most of the countries, where ST14 carried blaNDM in
almost all isolates (n = 17) in addition to blaOXA−48 like in few
(n = 5). Whereas, ST15 started to lose blaNDM that only carried
blaNDM gene in 6 out of 23 isolates. ST14 differed from ST15 in
their CPS gene profile and wcaJ. ST14 harbored k2a and wzyk
responsible for K2 serotype along withwcaJ gene. In addition, the
sequenced study isolate C4 belonging to ST2096 (variant of ST14)
carried rmpA and rmpA2, while lacking treC. Among ST15, only
one isolate fromUnited States carried k2a, wzyk2, and wcaJ while
others lacked these genes. Five out of 23 isolates harbored rmpA
and rmpA2.
luxS responsible for QS in K. pneumoniae was present in
almost all isolates irrespective of STs and countries. mrkD, and
treC were further analyzed for differences in mutation. mrkD
SNP analysis revealed six major mrkD variants among the
451 K. pneumoniae with 59 SNPS (Figure 5). In contrast, most
of the treC were mutated and the variants observed were diverse
with 135 SNPs (Figure 6). However, observed variants of treC
were strongly associated with the specific STs unlikemrkD.
Unlike K. pneumoniae, in K. quasipneumoniae each ST was
observed to be specific to each country. ST1813 was found
in India (C3, C5, and C6), ST489 and ST196 were found in
United States, whereas ST3870 and ST3876 were found in China.
All isolates harbored allS, iutA, fimH, mrkD, pilQ, ecpA, pgaA,
pgaB, pgaC, treC, wabG, and luxS. ST526 and ST668 lacked the
type I fimbriae gene fimA, wheres ST1818 from India lacked bcsA
gene responsible for adhesin. Except one, none of the isolates
harbored wzc for CPS but harbored treC and wabG instead. QS2
family gene luxSwas found in all isolates. Except ST3870, none of
the isolates harbored wcaJ gene.
For a better understanding of AMR genes across the globe,
country-wise distribution of carbapenemases and mcr genes
along with STs identified in the 454 K. pneumoniae genomes
analyzed in this study was depicted in Figure 7. blaKPC was
the dominant carbapenemase in United States and China,
whereas blaNDM was more or equal to blaOXA−48 like genes
in United Kingdom, Norway, Sweden, Japan and Korea. In
contrast, among India and Europe blaOXA−48 like was common.
In Australia, both blaIMP and blaKPC were observed. Interestingly,
mcr genes were observed in China, Taiwan, Thailand and
Vietnam. Distribution of plasmids among K. pneumoniae are
depicted in Figure 8. A total of 1286 plasmids were harbored
in 454 isolates with 1819 replicon types with IncFIB(K) and
IncFII being the most common. All six sequenced isolates
commonly harbored IncFIB(K)_Kpn3 plasmids in addition to
other replicon types.
Moreover, the association of genetic biofilm factors and AMR
genes were analyzed using scoary (Table 4). Genes observed
significant (p < 0.05) with Benjamini-Hochberg’s p-value were
only considered. blaIMP and blaVIM did not associate with any
of the screened biofilm genetic factors, whereas blaOXA−48 like,
blaNDM and blaKPC had significant associations with biofilm
genes co-carried with them.
DISCUSSION
The biofilm-forming capacity of clinical K. pneumoniae isolates
had a significant association with the outcome in respective
patients. Strong biofilm formation significantly reduced the
number of days alive for the patient to 3.33 days from the
poor/negative biofilm producing isolates with 11.33 days. This
clearly demonstrates the effect of biofilm formation as an
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FIGURE 5 | The phylogeny of mrkD was based on the maximum-likelihood tree with 59 SNPs from 451 K. pneumoniae. Isolates with similar SNP pattern were
clustered together for better representation. Six major variants were observed from the multi-alignment of SNPs. The STs did not exactly correlate with the variants of
mrkD, whereas multiples STs share same mrkD variants.
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FIGURE 6 | treC phylogeny was based on the maximum-likelihood tree with 135 SNPs from 451 K. pneumoniae. Isolates with similar SNP pattern were clustered
together for better representation. The STs correlate with the treC variants observed. Sequenced isolates C1, C2, and C4 did not harbor treC gene.
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FIGURE 7 | Country-wise distribution of carbapenemases and mcr genes in K. pneumoniae. Map outline was created using mapchart.net (https://mapchart.net/).
FIGURE 8 | Distribution of plasmid types (percentage) among 454 K. pneumoniae. A total of 1286 plasmids were harbored in 454 isolates with 1819 rep types.
Plasmids harboring single replicon type were 791, two replicons – 457, three replicons – 34, and four replicons were three plasmids.
association for increasing/accelerating the mortality. This is of
particular concern, as K. pneumoniae can survive for prolonged
periods in the hospital environment and grow attached to
inanimate surfaces like medical devices; catheters and ventilators
(Murphy and Clegg, 2012).
In such situations, polymicrobial infections might further
complicate the therapy. Monomicrobial or polymicrobial isolates
were identified in addition to K. pneumoniae among 45 out
of 72 patients. This includes, P. aeruginosa, Acinetobacter spp.,
Enterococcus spp., S. aureus, and Candida spp., P. aeruginosa
and A. baumannii were the most commonly co-infected bacterial
species followed by equal number of yeasts in these patients.
This could be attributed to the known persistence of these
pathogens in a hospital environment and their reported ability
for biofilm formation. Polymicrobial infections are known to
play an inevitable role in managing biofilm structure and
causing persistent infection, thereby challenging appropriate
antimicrobial therapy.
The biofilm structure has been known to fuel/protect the
pathogen even in stressful conditions in vivo, thereby resulting
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TABLE 4 | Association of biofilm genetic virulence factors with antimicrobial
resistance genes for carbapenem resistance in 454 K. pneumoniae isolates as
analyzed using scoary.
p-values
blaOXA−48 like mrkD
+ 0.01*
BcsA 0.08
WcaJ 0.05*
pgaA+ 0.05*
blaNDM mrkD
+ 0.03*
fimA 0.01*
pgaC 0.09
wcaJ 0.03*
iutA 0.04*
blaKPC mrkD 0.03*
fimA 0.06
fimH 0.03*
treC 0.09
mcr bcsA 0.02*
bcsB 0.002*
iutA 0.05*
+hypothetical proteins were significantly co-carried with these biofilm
genetic factors.
*p < 0.05; *p < 0.01.
in clinical failure irrespective of antimicrobial susceptibility. This
was clearly reflected in the 35% (n = 5) of clinical failure among
the carbapenem-susceptible infections (n = 14); three of the five
clinical failures were strong or moderate biofilm formers. Of the
remaining two, one patient had diabetes mellitus as a comorbid
condition while the other did not show any co-morbid condition.
However, more numbers are required to statistically confirm this
association. The clinical failure might be due to a hypervirulent
condition that needs further analysis for confirmation. Treatment
failure was observed in a proportion of patients who received
carbapenem monotherapy due to development of resistance,
particularly in those infected with biofilm forming strains.
This shows that biofilm producing strains develops resistance
rapidly upon antibiotic exposure and thus lead to addition or
change of antimicrobial agent. For CR K. pneumoniae, colistin
in combination with meropenem was prescribed. Further, for
carbapenem-colistin resistant K. pneumoniae, aminoglycosides
or tigecycline was added in combination for therapy.
The MBEC assay also confirms the findings, as C3, C5, C6
and C8 strains showed an increase from MICs of ≤0.03 µg/ml
(planktonic cells) to 2, 32, 128, and 4 µg/ml, respectively for
biofilms. These susceptibility results of carbapenem on the
fully-grown biofilm structure were consistent with the previous
reports for gentamicin, cefotaxime and ciprofloxacin, amikacin
and piperacillin in K. pneumoniae (Bellifa et al., 2013; Singla
et al., 2013). These were further validated by their AMR gene
composition, as C3, C5, and C6 (susceptible by MIC) harbored
only blaDHA and blaOKP−B, whereas C1, C2 and C4 harbored
strong carbapenemases such as blaNDM−5 and blaOXA−232.
However, C3 was intermediate resistant; C5 and C6 were resistant
to meropenem by MBEC assay, exhibiting the complexity of
antimicrobial action on biofilm structures. Remarkably, MBEC
assays further revealed that the planktonic cells released from
mature biofilm structure exhibited the same MICs as the biofilm
cells, which might possibly be a mechanism for establishment
of mobile resistant population in vivo causing clinical failure.
In contrast, as the MBEC levels are far greater than the MICs,
MICs cannot be extrapolated for treatment of biofilm-mediated
infections in the early stages. This signifies the importance of
an MBEC screening to determine the appropriate antimicrobial
dosing strength, which might require a combination therapy or
an increased dose of monotherapy.
Several scientific investigations have hypothesized various
physical mechanisms involved in promoting AMR due to biofilm
formation. One of the commonly proposed methods has been
the ability of biofilm matrix to prevent efficient diffusion
of antibiotics, leading to significantly decreased exposure of
bacteria in biofilms, in addition to development of resistance
due to altered gene expression of antibiotic tolerance genes,
and horizontal transfer of AMR genes between cells in a
biofilm environment (Lewis, 2008; Lazar and Chifiriuc, 2010).
In K. pneumoniae, it was reported that ampicillin was steadily
degraded as it diffused through biofilm matrix. Ciprofloxacin
could penetrate the biofilm but could not kill the bacterial cells as
they become tolerant at nutrient limited conditions (Anderl et al.,
2000, 2003). In addition, antibiotics piperacillin, piperacillin-
tazobactam, cefoperazone, ceftazidime, cefepime, meropenem,
ciprofloxacin, netilmicin and amikacin were proven to exhibit
reduced activity against adherent bacteria when compared to the
planktonic counterparts (Cernohorská and Votava, 2004).
The genetic mechanisms known to be involved for a successful
biofilm formation in K. pneumoniae include factors for adhesion
(fimbriae and pili) (Alcántar-Curiel et al., 2013), cohesion
(adhesins, polysaccharides), CPS (Wu et al., 2011), QS (Chen
et al., 2020), and loss of mucoidal nature (colanic acid) (Pal
et al., 2019). Here, genes responsible for each of these factors
were analyzed for the study isolates in comparison with global
clones. Though a few reports suggest recombination between
K. variicola and K. quasipneumoniae (Long et al., 2017), and
between K. quasipneumoniae and K. pneumoniae (Holt et al.,
2015), most of the studies report that homologous recombination
does not occur between strains in the different clades (Brisse
et al., 2014). Similarly, the phylogenetic analysis in the present
study revealed significant differences betweenK. pneumoniae and
K. quasipneumoniae and hence they were studied separately for
further analysis.
Fimbriae and pili structures are known for their ability to
support motility as well as attachment to a biotic or an abiotic
surface, essential in the initial stages of biofilm formation. Firstly,
it was considered that type I fimbriae are not as important
as type III fimbriae for biofilm formation. This was due to
exclusive adhesive property by MrkD protein at the tip of the
fimbriae, which aids in pathogenesis by better attachment of
K. pneumoniae, (i) to the basolateral surfaces in vivo such as
urinary tract or bronchial epithelia (Murphy and Clegg, 2012);
(ii) to damaged mucosal surfaces caused due to insertion of
indwelling devices like catheters, as well as adherence to the
surfaces of these devices which would be coated with host-
derived conjugates (Tarkkanen et al., 1990; Miettinen et al., 1993).
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However, recent investigations have indicated that either type I or
type III fimbriae may play a role in biofilm formation (Stahlhut
et al., 2012). Accordingly, in the present study all six sequenced
isolates harbored genes responsible for both type I (fimA and
fimH) and type III (mkrD) fimbriae. Also, these genes were
present irrespective of STs across all global clones.
Several allelic variants of mrkD have been identified in
different Klebsiella isolates. These alleles are known to be
associated with different binding specificities to matrix material
such as collagen (Huang et al., 2006). Interestingly, isolates
belonging to different STs shared the same mrkD variant. ST11
and ST258, in addition to belonging in the same CC (CC11),
shared the same mrkD variant. Moreover, the sequenced isolates
JAALJK0.1 and JAALJ01.1 from a different ST (ST395) also
belonged to the same clade ofmrkD. The low number of variants
observed in mrkD of 454 K. pneumoniae exhibit them as a stable
genetic factor for biofilm mechanism across all STs.
The E. coli common pilus (ecp) and pilQ are known to be
important in regulation of pili function in K. pneumoniae. In the
present study, ecpA and pilQ were observed in almost all isolates
of K. pneumoniae and K. quasipneumoniae. Similarly, Alcántar-
Curiel et al. (2013) reported that 96% of the K. pneumoniae
strains contained ecpA with a 94% phenotypic correlation of ECP
production crucial to form an adhesive structure on cultured
epithelial cells. Among K. pneumoniae sequenced in this study,
one ST2096 (CC14) was negative for ecpA, while pilQ was
absent only in two of the K. pneumoniae belonging to ST395.
In K. quasipneumoniae, all three isolates harbored both ecpA and
pilQ genes.
Although genes responsible for adhering structure were
shown to be present, the actual secretory polysaccharides and
other adhesins play a critical role in physical attachment that
enhances biofilm formation. pgaABCD and bcsA were highly
reported adhesins in K. pneumoniae (Chen K. M. et al., 2014;
Wang et al., 2016). The adhesin gene profile correlated with
the particular STs. Accordingly, ST11, ST15, ST14, and ST16
carried all four genes; ST258 and ST307 carried pgaA, pgaC,
and bcsA; ST23 carried pgaB, pgaC, and bcsA; while ST101,
ST147, ST231, and ST395 carried only pgaC and bcsA. Chen
K. M. et al. (2014) previously reported that the loss of pgaC
affected the production of poly-β-linked N-acetylglucosamine
which in turn had inhibitory effects on in vitro biofilm formation.
Among the six sequenced isolates, none of them harbored
bcsA. K. quasipneumoniae harbored all three pga gens, while in
K. pneumoniae two isolates harbored pgaC and one harbored
pgaB and pgaC genes.
Lipopolysaccharides are known to be involved in the initial
adhesion on abiotic surfaces and capsule plays a critical role in
construction of mature biofilm architecture (Balestrino et al.,
2008). wzc, cpsD, and treC have been reported to be key
regulators in the CPS production (Wu et al., 2011). Since ST23
were the only isolates found to harbor wzc genes in the study
population, they were further analyzed for their efficiency in
hyper-capsulation due to a 565 glycine-to-serine substitution
in wzc genes. None of the ST23 isolates carried Gly-565Ser
substitution, known for hyper-capsulation. A recent study by
Ernst et al. (2020) revealed that disruption/absence of wzc
might cause the hyper-capsulation required for biofilm formation
irrespective of rmpA/A2. Accordingly, ST23 had genes exclusively
for hypervirulence characteristics such as wcaG, magA, and
rmpA/A2, although they might not be good biofilm producers.
treC was found to be crucial for capsule production and
biofilm formation via trehalose utilization/CPS modulation (Wu
et al., 2011). treC was identified in almost all study isolates of
K. pneumoniae and K. quasipneumoniae. Though, there was a
correlation between the STs and SNPs within treC gene; the
variants observed were diverse. Moreover, variants of mrkD, wzc
and treC genes in these isolates requires further gene knock-
out studies to analyze the effect of these variants among clinical
K. pneumoniae.
Furthermore, factors well known for hypervirulence, such as
allS, iutA, rmpA/A2, magA, K2A, wabG, and wcaG were also
reported for their role in biofilm formation and magA, K2a,
rmpA/A2,wabG, andwcaGwere shown to regulate CPS synthesis
(Zheng et al., 2018; Hasani et al., 2020). In fact, wcaG was proven
to be an independent risk factor for biofilm formation and highly
associated with ST23 (Zheng et al., 2018). In line with this, these
factors were also identified in isolates analyzed in this study.wcaG
andmagAwere exclusive to ST23, whereas rmpA and rmpA2were
seen majorly in ST23, in addition to C4 (ST2096) and other few
STs. Almost all rmpA/A2 observed were plasmid mediated.
QS is a well-established mechanism in the process of biofilm
formation, where the population is regulated on sensing the cell-
cell contact (Chen et al., 2020). Type II QS system reported
in K. pneumoniae showed the role of luxS in autoinducer AI-
2 synthesis (Balestrino et al., 2005; Zhu et al., 2011). It was
also noted that changes in biofilm architecture were observed in
the luxS mutant K. pneumoniae with less surface coverage and
reduced macrocolony formation (Chen et al., 2020). luxS was
present in almost all isolates in the study irrespective of STs.
A recent study by Pal et al. (2019) reported that loss or
disrupted wcaJ (glycosyltransferase for colonic acid production)
in K. pneumoniae made the isolates less mucoidal and higher
in biofilm forming efficiency leading to reduced susceptibility
toward both polymyxins and macrophages (less immunogenic).
Except ST3870, none of the K. quasipneumoniae harbored wcaJ
gene. While in K. pneumoniae, wcaJ was restricted to ST14,
ST23, ST147, and part of ST11. Interestingly, ST15, ST16, ST307,
and ST258, reported global high-risk clones, were wcaJ negative
indicating the high potential of biofilm forming capacity in these
STs. Sequenced isolates did not harbor wcaJ except C1 (ST395).
The common ST observed among the three
K. quasipneumoniae (ST1813) suggested the common structural
genome backbone which is reflected by carrying of same biofilm
and ß-lactamase genes. However, the ß-lactamase genes observed
in K. pneumoniae were different due to the diverse plasmid
carrying capacities of K. pneumoniae irrespective of the same
sequence type. Some of the previous studies report association
of phenotypic biofilm forming efficiency with the AMR genes in
K. pneumoniae (Vuotto et al., 2014). In clinical K. pneumoniae,
it was reported that 44.7% were biofilm formers and 45.3%
were ESBLs producers (Yang and Zhang, 2008). However, there
was a lacuna of genetic factors being compared for biofilm
mechanism with such AMR genes. Results observed in this study
clearly exhibit the strong association of genes responsible for
biofilm formation and AMR. Though, blaIMP and blaVIM did not
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associate with any of the screened biofilm genetic factors, it was
evident that blaOXA−48 like, blaNDM and blaKPC had significant
(p < 0.05) associations with biofilm genes, especially mrkD
with all three genes. In addition, gene encoding hypothetical
proteins with significant (p < 0.05) associations alongside mrkD
and pgaA were identified. Gene knockout studies on these
genes encoding hypothetical proteins will reveal their role in
regulating biofilm formation. Further, expression analysis is need
for better comparison of strong, moderate, and non-biofilm
producing strains.
Limitations of the study include, that the study retrospectively
used isolates obtained from blood or endotracheal aspirate
for biofilm screening. Also, the study included only complete
genomes from NCBI to generate a high-quality phylogeny
output so as to avoid bias in the core vs accessory genes
being characterized which occurred with the shot-gun genome
sequences (data not shown). The small number of complete
genomes available in few of the STs included in the analysis
significantly limited the ability to arrive at definitive conclusions
on certain gene correlations.
CONCLUSION
A single genetic factor is not always adequate, rather it requires
a set of genetic factors to facilitate the complete formation
of biofilm. Accordingly, this study discussed various genetic
factors involved in biofilm formation of K. pneumoniae and
K. quasipneumoniae, which cluster to provide a combined effect
called biofilm. These results highlight the importance of biofilm
testing, especially for nosocomial infections that are difficult
to clear in vivo. Accordingly, genes mrkD, wcaJ, pgaA, and
pgaC in addition to fimA, fimH, and treC could be potential
screening RT-PCR markers for rapid diagnostics of biofilms in
K. pneumoniae. These infections require additional treatment
that might effectively help in improving patient outcome.
Further, information on the clonal spread of biofilm forming
K. pneumoniae across the globe will help to understand the
dynamics of biofilm infections thereby paving way for effective
management of nosocomial infections.
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